Thomas Collet
Title: Mentor-in-Residence
Phone: 734-358-9015
Email: tacollet@alum.mit.edu
Thomas's focus is on building new businesses and growing existing businesses through the development and commercialization of new products, technologies, and services in the life science and medical industries, with emphasis on the North American and European markets.
Thomas is currently President and CEO of Meditrina Pharmaceuticals, Inc. and a co-founder. Prior to Meditrina, Thomas served as President and CEO of four early-stage life science companies which he was instrumental in creating, building and financing. The companies were: Rubicon Genomics, a drug discovery and development tools and biomarker discovery company; Phrixus Pharmaceuticals, a heart failure company; ProNAi Therapeutics, a cancer therapeutics company; and Neural Intervention Technologies (NIT), a medical device company developing a therapy for the treatment of hemorrhagic stroke. Previously, he was a general partner at Tullis-Dickerson (TD), where he helped manage a $40 million seed and early stage fund. Prior to his tenure at TD, Thomas was VP, Business Development at Monsanto where he helped start Integrated Protein Technologies, the Company’s internal venture for the production of pharmaceutical proteins in green plants. Thomas started his career with McKinsey & Company, Inc, where he advised clients in Europe and in the US on strategy and operations in the healthcare and pharmaceutical industries. At McKinsey, his clients were primarily small, technology-focused business units of Fortune 100 companies.
Cumulatively, Thomas’s four companies have raised more than $24 million in seed and early-stage capital since 2001 from venture capitalists, pharmaceutical companies, individual investors and government programs. Of particular note is NIT, which was supported by the State of Michigan Technology Tri-Corridor. It was sold to W.L. Gore in 2006, generating the largest cash return for this program since its inception.
Printed from: http://techtransfer.umich.edu/about/bio_thomas_collet.php